Publications by authors named "Koen Rovers"

Claim this Profile
T
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.
Alexander Constantinides, Nico Lansu, Peter Mosen, Paulien Rauwerdink, Esther Strating, Koen Rovers

Transl Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.
Felice N van Erning, Teun B M van den Heuvel, Femke P C Sijtsma, Djamila Boerma, Alexandra R M Brandt-Kerkhof, Koen P Rovers

Eur J Surg Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic chemotherapy in addition to CRS-HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival.
Teun B M van den Heuvel, Robin J Lurvink, Koen P B Rovers, Irene E G van Hellemond, Ignace H J T de Hingh

J Surg Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II).
Vincent C J van de Vlasakker, Paulien Rauwerdink, Koen P B Rovers, Emma C Wassenaar, Geert-Jan Creemers

Surg Endosc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
Paulien Rauwerdink, Vincent C J van de Vlasakker, Emma C E Wassenaar, Koen P Rovers, Maartje Los

Eur J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
Roos G F M van der Ven, Teun B M van den Heuvel, Koen P B Rovers, Simon W Nienhuijs, Djamila Boerma

Ann Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
Roos G F M van der Ven, Teun B M van den Heuvel, Koen P B Rovers, Simon W Nienhuijs, Felice N van Erning

Ann Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
Vincent C J van de Vlasakker, Robin J Lurvink, Emma C Wassenaar, Paulien Rauwerdink, Checca Bakkers, Koen P Rovers

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
Anouk Rijken, Vincent C J van de Vlasakker, Geert A Simkens, Koen P Rovers, Felice N van Erning

Clin Exp Metastasis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Patient-Reported Outcomes of the CAIRO6 Phase II Trial.
Checca Bakkers, Koen P Rovers, Anouk Rijken, Simon W Nienhuijs, Ignace H J T de Hingh

Ann Surg Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the origin of peritoneal metastases.
Anouk Rijken, Felice N van Erning, Koen P Rovers, Valery E P P Lemmens, Ignace H J T de Hingh

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study.
Checca Bakkers, Vincent C J van de Vlasakker, Koen P B Rovers, Robin J Lurvink, Simon W Nienhuijs

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).
Robin J Lurvink, Koen P Rovers, Emma C E Wassenaar, Checca Bakkers, Jacobus W A Burger

Surg Endosc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Olivia Sgarbura, Clarisse Eveno, Mohammad Alyami, Naoual Bakrin, Delia Cortes Guiral, Koen P Rovers

Pleura Peritoneum· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights on the Treatment of Colorectal Peritoneal Metastases From the CAIRO6 Trial-Reply.
Koen P Rovers, Checca Bakkers, Ignace H J T de Hingh

JAMA Surg· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases.
Koen P Rovers, Robin J Lurvink, Simon W Nienhuijs, Ignace H J T de Hingh

Ann Surg Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
Koen P Rovers, Emma C E Wassenaar, Robin J Lurvink, Geert-Jan M Creemers, Jacobus W A Burger

Ann Surg Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
Koen P Rovers, Checca Bakkers, Simon W Nienhuijs, Jacobus W A Burger, Geert-Jan M Creemers

JAMA Surg· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC.
Geert A Simkens, Anne G W E Wintjens, Koen P Rovers, Simon W Nienhuijs, Ignace H de Hingh

Cancer Manag Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid.
Iris Van't Erve, Koen P Rovers, Alexander Constantinides, Karen Bolhuis, Emma Ce Wassenaar

J Pathol Clin Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of the PRODIGE 7 trial.
Koen P Rovers, Niels F M Kok, Cornelis J A Punt, Pieter J Tanis, Ignace H J T de Hingh

Lancet Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Phase I dose escalation study of oxaliplatin delivered via a laparoscopic approach using pressurized intraperitoneal aerosol chemotherapy (PIPAC) for advanced peritoneal metastases of gastrointestinal tract cancers: PIPAC-oxaliplatin for peritoneal metastases of gastrointestinal cancers.
Koen P Rovers, Robin J Lurvink, Maarten J Deenen, Ignace H J T de Hingh

Eur J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.
Robin J Lurvink, Koen P Rovers, Simon W Nienhuijs, Geert-Jan Creemers, Jacobus W A Burger

J Gastrointest Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.
Robin J Lurvink, Kurt Van der Speeten, Koen P Rovers, Ignace H J T de Hingh

J Gastrointest Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
Robin J Lurvink, Paulien Rauwerdink, Koen P Rovers, Emma C E Wassenaar, Maarten J Deenen

BMJ Open· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis